Barbara Dymek

466 total citations
13 papers, 230 citations indexed

About

Barbara Dymek is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Barbara Dymek has authored 13 papers receiving a total of 230 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Barbara Dymek's work include Studies on Chitinases and Chitosanases (6 papers), Invertebrate Immune Response Mechanisms (2 papers) and Adipose Tissue and Metabolism (1 paper). Barbara Dymek is often cited by papers focused on Studies on Chitinases and Chitosanases (6 papers), Invertebrate Immune Response Mechanisms (2 papers) and Adipose Tissue and Metabolism (1 paper). Barbara Dymek collaborates with scholars based in Poland, Netherlands and Denmark. Barbara Dymek's co-authors include Dino Demirovic, Suresh I. S. Rattan, Cristóvão F. Lima, Ricardo A. Fernandes, Karolina Dzwonek, Monika Lamparska‐Przybysz, Maciej Wieczorek, Daria Zdżalik-Bielecka, Agnieszka Zagożdżon and Adam Gołȩbiowski and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Hepatology and European Journal of Pharmacology.

In The Last Decade

Barbara Dymek

12 papers receiving 220 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara Dymek Poland 7 109 47 47 37 26 13 230
Letícia Meneguello Brazil 8 201 1.8× 22 0.5× 43 0.9× 39 1.1× 22 0.8× 10 310
Samar Al Bitar Lebanon 5 170 1.6× 33 0.7× 101 2.1× 24 0.6× 28 1.1× 9 315
Laifeng Ren China 11 276 2.5× 34 0.7× 49 1.0× 29 0.8× 37 1.4× 21 387
Tonggang Qi China 13 188 1.7× 46 1.0× 58 1.2× 29 0.8× 21 0.8× 21 347
Jin Sil Chung South Korea 8 188 1.7× 53 1.1× 58 1.2× 21 0.6× 27 1.0× 8 311
Wei Zeng China 11 134 1.2× 27 0.6× 30 0.6× 19 0.5× 21 0.8× 34 318
Joel McCauley United States 10 264 2.4× 34 0.7× 35 0.7× 51 1.4× 30 1.2× 12 398
Christopher M. Schafer United States 11 193 1.8× 30 0.6× 17 0.4× 36 1.0× 19 0.7× 17 296
Juhua Dan China 11 117 1.1× 44 0.9× 41 0.9× 36 1.0× 25 1.0× 28 297
Lixia Wang China 8 232 2.1× 59 1.3× 112 2.4× 14 0.4× 44 1.7× 11 388

Countries citing papers authored by Barbara Dymek

Since Specialization
Citations

This map shows the geographic impact of Barbara Dymek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Dymek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Dymek more than expected).

Fields of papers citing papers by Barbara Dymek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Dymek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Dymek. The network helps show where Barbara Dymek may publish in the future.

Co-authorship network of co-authors of Barbara Dymek

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Dymek. A scholar is included among the top collaborators of Barbara Dymek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Dymek. Barbara Dymek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Sklepkiewicz, Piotr, Barbara Dymek, Agnieszka Zagożdżon, et al.. (2023). Inhibition of Macrophage-Specific CHIT1 as an Approach to Treat Airway Remodeling in Severe Asthma. International Journal of Molecular Sciences. 24(5). 4719–4719. 7 indexed citations
2.
Górska, Katarzyna, Marta Maskey‐Warzęchowska, Małgorzata Proboszcz, et al.. (2022). The Role of Chitinases in Chronic Airway Inflammation Associated with Tobacco Smoke Exposure. Cells. 11(23). 3765–3765. 4 indexed citations
3.
Dymek, Barbara, Piotr Sklepkiewicz, Patrycja Nejman‐Gryz, et al.. (2022). Pharmacological Inhibition of Chitotriosidase (CHIT1) as a Novel Therapeutic Approach for Sarcoidosis. Journal of Inflammation Research. Volume 15. 5621–5634. 11 indexed citations
4.
Dymek, Barbara, et al.. (2020). Therapeutic efficacy of the chitotriosidase inhibitors in STAM model of non-alcoholic steatohepatitis. Journal of Hepatology. 73. S451–S451. 1 indexed citations
5.
Błaszczyk, Roman, Barbara Dymek, Marcin Mazurkiewicz, et al.. (2020). Discovery and Pharmacokinetics of Sulfamides and Guanidines as Potent Human Arginase 1 Inhibitors. ACS Medicinal Chemistry Letters. 11(4). 433–438. 30 indexed citations
6.
Dymek, Barbara, Karolina Dzwonek, Paweł Dobrzański, et al.. (2018). Late Breaking Abstract - Phase 1, first-in-human study of OATD-01, a dual chitinase inhibitor for the treatment of respiratory diseases. PA5228–PA5228. 2 indexed citations
7.
8.
Dymek, Barbara, Piotr Sklepkiewicz, Agnieszka Zagożdżon, et al.. (2017). The therapeutic efficacy of OAT-889 (dual AMCase/CHIT1 inhibitor) in comparison to montelukast in HDM-induced model of chronic airway inflammation in mice. PA4684–PA4684. 1 indexed citations
9.
Dymek, Barbara, et al.. (2015). Differences in gene expression and alterations in cell cycle of acute myeloid leukemia cell lines after treatment with JAK inhibitors. European Journal of Pharmacology. 765. 188–197. 4 indexed citations
10.
Stefaniak, Filip, Daria Zdżalik-Bielecka, Barbara Dymek, et al.. (2015). Discovery of TRAF-2 and NCK-interacting kinase (TNIK) inhibitors by ligand-based virtual screening methods. MedChemComm. 6(8). 1564–1572. 3 indexed citations
11.
Zdżalik-Bielecka, Daria, et al.. (2014). Activating mutations in ALK kinase domain confer resistance to structurally unrelated ALK inhibitors in NPM-ALK-positive anaplastic large-cell lymphoma. Journal of Cancer Research and Clinical Oncology. 140(4). 589–598. 26 indexed citations
12.
Dymek, Barbara, et al.. (2014). Epithelial–mesenchymal transition confers resistance to selective FGFR inhibitors in SNU-16 gastric cancer cells. Gastric Cancer. 19(1). 53–62. 53 indexed citations
13.
Rattan, Suresh I. S., Ricardo A. Fernandes, Dino Demirovic, Barbara Dymek, & Cristóvão F. Lima. (2008). Heat Stress and Hormetin-Induced Hormesis in Human Cells: Effects on Aging, Wound Healing, Angiogenesis, and Differentiation. Dose-Response. 7(1). 90–103. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Letícia Meneguello Breakdown of academic impact, for papers by Samar Al Bitar Breakdown of academic impact, for papers by Laifeng Ren Breakdown of academic impact, for papers by Tonggang Qi Breakdown of academic impact, for papers by Jin Sil Chung Breakdown of academic impact, for papers by Wei Zeng Breakdown of academic impact, for papers by Joel McCauley Breakdown of academic impact, for papers by Christopher M. Schafer Breakdown of academic impact, for papers by Juhua Dan Breakdown of academic impact, for papers by Lixia Wang
Rankless by CCL
2026